Technology
Health
Medical

BioLife Solutions

$20.39
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.19 (0.94%) As of 2:36 PM EDT today
+$0.19 (0.94%) Today

Why Robinhood?

You can buy or sell BLFS and other stocks, options, ETFs, and crypto commission-free!

About BLFS

BioLife Solutions, Inc. engages in the development, manufacture, and marketing of biopreservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; and custom product formulation and custom packaging services. Read More The company was founded by Boris Rubinsky in 1998 and it is headquartered in Bothell, WA.

Employees
54
Headquarters
Bothell, Washington
Founded
1998
Market Cap
406.08M
Price-Earnings Ratio
149.08
Dividend Yield
0.00
Average Volume
214.90K
High Today
$20.60
Low Today
$19.98
Open Price
$20.03
Volume
47.69K
52 Week High
$26.35
52 Week Low
$9.15

Collections

Technology
Health
Medical
Media
Advertising and Marketing
Packaging
Business Services
US

BLFS News

ReutersAug 10

Edited Transcript of BLFS earnings conference call or presentation 8-Aug-19 8:30pm GMT

23

BLFS Earnings

-$0.05
-$0.02
$0.02
$0.05
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
$0.02 per share
Actual
$0.04 per share

More BLFS News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.